Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

binetrakin

A recombinant agent chemically identical to or similar to the endogenous cytokine interleukin-4 (IL-4). Produced primarily by activated T cells, IL-4 binds to and activates its cell-surface receptor, stimulating the proliferation and differentiation of activated B cells and enhancing their ability to present antigens to T cells. As a potential immunotherapeutic agent, binetrakin also augments the effects of other cytokines on dendritic cells (DC), cytotoxic T lymphocytes (CTL), and tumor-infiltrating lymphocytes (TIL).
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:B-cell growth factor
B-cell proliferating factor
B-cell stimulating factor
B-cell stimulatory factor 1
interleukin 4 (human) 129
interleukin-4
mast cell growth factor-2
recombinant human IL-4
T-cell growth factor 2
Abbreviation:BCGF
BCSF 1
IL-4
MCGF 2
RHIL-4
Code name:SCH 93400
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search